Transfuse Exagamglogene in Periph Vein, Perc, New Tech 8

This code represents the administration of Exagamglogene Autotemcel, a gene-edited cellular therapy, directly into a patient's peripheral vein. This process involves the infusion of the patient's own modified hematopoietic stem cells, which have been engineered to produce functional hemoglobin, aiming to treat specific genetic blood disorders.

This code is used when a patient receives Exagamglogene Autotemcel via an intravenous infusion into a peripheral vein, typically for the treatment of severe sickle cell disease or transfusion-dependent beta-thalassemia. It applies to the actual administration of this novel cellular therapy following myeloablative conditioning.

• Ensure documentation clearly specifies "Exagamglogene Autotemcel" as the substance infused, not just a generic stem cell transplant.
• Verify the approach is explicitly documented as "peripheral vein" and "percutaneous."
• This code is for the infusion itself; separate codes will be needed for conditioning regimens, apheresis, and other associated procedures.